A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART - Gómez, Carmen Elena (Centro Nacional de Biotecnología (Madrid, Espanya)) ; Perdiguero, Beatriz (Centro Nacional de Biotecnología (Madrid, Espanya)) ; García-Arriaza, Juan (Centro Nacional de Biotecnología (Madrid, Espanya)) ; Cepeda, Victoria (Centro Nacional de Biotecnología (Madrid, Espanya)) ; Sánchez-Sorzano, Carlos Óscar (Centro Nacional de Biotecnología (Madrid, Espanya)) ; Mothe, Beatriz (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Jiménez, José Luis (Hospital General Universitario Gregorio Marañón) ; Muñoz-Fernández, María Ángeles (Hospital General Universitario Gregorio Marañón) ; Gatell, José María (Hospital Clínic i Provincial de Barcelona) ; López Bernaldo de Quirós, Juan Carlos (Hospital General Universitario Gregorio Marañón) ; Brander, Christian (Institució Catalana de Recerca i Estudis Avançats) ; García, Felipe (Hospital Clínic i Provincial de Barcelona) ; Esteban, Mariano (Centro Nacional de Biotecnología (Madrid, Espanya)) ; Universitat Autònoma de Barcelona

Comments (0) | Reviews (0)

Be the first to review this document.

Add review

Rate this article:

Give a title to your review:

Write your review:

Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.

Similar records